lisocabtagene maraleucel
bms
['liso-cel', 'transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)', 'lymsm', 'cml']
drs. &amp; published a subgroup analysis of the 2nd-line liso-cel transform trial regarding outcomes by prior therapy response. #17icml #lymsm 
The official account for the @CUMedicalSchool @CUAnschutz Lymphoma Program. #lymsm